Lattice Biologics Ltd LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

GREY:LBLTF - Post by User

Lattice Biologics Ltd > to transport COVID-19 vaccines developed liquid nitrogen to

<< Previous

Bullboard Posts

Next >>

Comment by luvhorseson Jan 20, 2021 9:11am

58 Views

Post# 32332247

RE:to transport COVID-19 vaccines developed liquid nitrogen to

Dudes, v.LBL is bang on with their game plan...Q report will solidified what mgmt has been reporting based on their previous Q report from Aug.

We're @ ground level here with v.LBL :)
Another ground level and ground breaking one is c.TTX....lithium...a good one to check out. Biden's speech will set the pace for us there for sure :)

<< Previous

Bullboard Posts

Next >>

Transportation technology stock secures second major contract in a week